DEIRDRA TAYLOR: Open Payments
NPI 1407623440 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $167 · 2025 $600
Food & beverage: $489Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $163 |
| Alkermes, Inc. | 6 | $137 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: ARISTADA, COBENFY, LYBALVI, INGREZZA, ABILIFY MAINTENA, FANAPT, CAPLYTA, UZEDY.
Industry payments across TN — which companies pay providers there.
